Jeff Packman is Vice President Drug Development Operations for FoldRx Pharmaceuticals, Inc. and is responsible for advancing FoldRx's drug candidates into and through clinical development. Jeff brings over 13 years of international experience in drug development and operations management. Prior to joining FoldRx, Jeff headed Drug Development Operations and Project and Alliance Management at Oscient Pharmaceuticals. At Oscient, he was Project Leader for the company's two clinical development candidates and was responsible for building and directing all operational activities for Oscient's clinical development programs.
Before joining Oscient Pharmaceuticals, Jeff was Associate Director of Worldwide Business Operations for the Regulatory Affairs division of PAREXEL International Corp., a multi-national contract research organization serving the pharmaceutical and biotechnology industries. At PAREXEL, Jeff was responsible for directing the worldwide operations of two groups within the Regulatory Affairs function, Regulatory Operations and Business Operations, and was a member of the company's North American Operating Committee.
Jeff received a Bachelor's in Biology from Colby College and a Master's of Business Administration with Highest Honors from the F.W. Olin Graduate School of Business Administration at Babson College.
|